-transparent.png){kind=logo}
2-Acetylaminofluorene (AAF), 2-aminofluorene (AF) and N-hydroxy-2-acetylaminofluorene (N-OH-AAF) could be activated to mutagens in S. typhimurium using either 9000 g supernatant (S9) or hepatocytes isolated from rats, mice, hamsters or guinea pigs. Their relative mutagenic potency was generally N-OH-AAF greater than AF greater than AAF. Monolayer cultures of hepatocytes exposed to AAF/AF/N-OH-AAF showed evidence of DNA damage measured as unscheduled DNA repair synthesis. The order of activity in rat and hamster was N-OH-AAF greater than AAF greater than AF, in guinea pig and mouse N-OH-AAF greater than AF greater than AAF. Only N-OH-AAF caused observable cytotoxicity, and the rat hepatocytes were the far more sensitive species. Neither the resistance of guinea pig liver nor the greater susceptibility of the rat liver to the carcinogenic effects of AAF and N-OH-AAF could be readily explained by the species differences in activating these compounds to mutagens in Salmonella or to DNA damaging agents in the hepatocytes. It is possible that cytotoxic effects of N-OH-AAF may be of some importance for the observed species differences in the liver carcinogenic effects of AAF and N-OH-AAF.
J A Holme, and
E J Søderlund
October 1994,
Mutation research,
J A Holme, and
E J Søderlund
June 1995,
Journal of molecular biology,
J A Holme, and
E J Søderlund
January 1984,
Teratogenesis, carcinogenesis, and mutagenesis,
J A Holme, and
E J Søderlund
January 1989,
Drug and chemical toxicology,
J A Holme, and
E J Søderlund
November 1982,
Cancer research,
J A Holme, and
E J Søderlund
January 1988,
Mutation research,
J A Holme, and
E J Søderlund
February 1991,
Cancer letters,
J A Holme, and
E J Søderlund
June 1963,
Cancer research,
J A Holme, and
E J Søderlund
October 1980,
Cancer research,
J A Holme, and
E J Søderlund
November 1986,
Mutation research,
